Myeloma Ig Id-KLH Conjugate Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A vaccine consisting of myeloma-specific immunoglobulin conjugated to keyhole limpet hemocyanin (KLH), an immune stimulant, with potential antineoplastic activity. Vaccination with myeloma Ig Id-KLH conjugate vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against myeloma cells, resulting in decreased tumor growth. (NCI04)

**Synonyms:** - Id KLH Myeloma - Idiotype KLH Myeloma Vaccine